Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Mounjaro (tirzepatide): EPAR product information
Scenario 5: microdosing compounded tirzepatide Using a microdosing approach at 1 to 2.5 mg weekly, extending a standard vial to 2 to 3 months instead of 1 month
Our brain-first nasal format is guided by licensed providers, compounded by LegitScript-certified pharmacies, with protocols continuously refined by a Stanford PhD-led Research Team studying real-world outcomes across 25,000+ Glutathione users
Small shifts still matter
After all of your questions are answered, instructions are given, your provider will depart
FDA approval status Tirzepatide is FDA-approved only as an injectable medication under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for weight loss)
US$ 21.02
US$ 20.85
US$ 25.26
US$ 26.82
US$ 26.73
US$ 28.24
